La gestion des effets secondaires sous traitement hormonal de la ménopause : saignements utérins anormaux. RPC Les femmes ménopausées du CNGOF et du GEMVi

N. Hamdaoui; L. Boubli

doi:10.1016/j.gofs.2021.03.028

La gestion des effets secondaires sous traitement hormonal de la ménopause : saignements utérins anormaux. RPC Les femmes ménopausées du CNGOF et du GEMVi

N. Hamdaoui, L. Boubli

In: Gynécologie Obstétrique Fertilité & Sénologie · 2021 · vol. 49(5) , pp. 474–484 · doi:10.1016/j.gofs.2021.03.028 · PMID:33757921 · W3136474595

article OA: closed CC0 ⤵ 1 in-corpus citation

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper discusses the management of abnormal uterine bleeding in menopausal women undergoing hormone therapy, according to recommendations from CNGOF and GEMVi.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

Cited by (1)

Treatment in Endometrial Thickening of Postmenopausal Women 2023

References (39)

A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness via openalex
Endometrial evaluation with transvaginal ultrasound during hormone therapy: a prospective multicenter study via openalex
Postmenopausal vaginal bleeding in women using hormone replacement therapy via openalex
doi:10.1016/s0140-6736(94)91640-3 via openalex
doi:10.1046/j.1469-0705.2002.00800.x via openalex
doi:10.1097/00042192-199906030-00005 via openalex
doi:10.1007/bf02940316 via openalex
doi:10.1016/s1074-3804(96)80102-2 via openalex
doi:10.1016/s0378-5122(01)00245-6 via openalex
doi:10.1097/gme.0b013e3180333a6b via openalex
doi:10.1097/pgp.0000000000000344 via openalex
doi:10.1136/bmj.315.7099.37 via openalex
doi:10.1080/cmt.5.1.60.69 via openalex
doi:10.1016/s0378-5122(02)00272-4 via openalex
doi:10.1080/13697130310001651481 via openalex
doi:10.1016/0002-9378(95)90483-2 via openalex
doi:10.1007/s00404-010-1604-0 via openalex
doi:10.1002/14651858.cd000402.pub4 via openalex
doi:10.3109/13697137.2014.999661 via openalex
doi:10.1136/bmj.299.6699.601-a via openalex
doi:10.1016/j.jmig.2007.10.014 via openalex
doi:10.1016/s0301-2115(99)00115-3 via openalex
doi:10.1111/aogs.13022 via openalex
doi:10.1158/1055-9965.1459.13.9 via openalex
doi:10.1046/j.1365-2125.2002.01683.x via openalex
W2396298721 via openalex
W2464049621 via openalex
W6640352210 via openalex
W6654129639 via openalex
doi:10.1002/14651858.cd000402.pub3 via openalex
doi:10.1001/jama.1996.03530290040035 via openalex
doi:10.1001/jama.280.17.1510 via openalex
doi:10.1001/jama.288.3.321 via openalex
doi:10.1046/j.1469-0705.2000.00091.x via openalex
doi:10.1016/s1297-9589(02)00336-3 via openalex
doi:10.1016/s0029-7844(01)01598-8 via openalex
doi:10.1016/0029-7844(95)00172-n via openalex
doi:10.1016/s0378-5122(00)00115-8 via openalex
doi:10.1016/s0015-0282(16)58329-0 via openalex

Cited by (1)

Treatment in Endometrial Thickening of Postmenopausal Women 2023

Source provenance

openalex: last seen: 2026-05-14T06:02:11.780192+00:00

License: CC0 · commercial use OK

[1] A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness 2005

[2] Endometrial evaluation with transvaginal ultrasound during hormone therapy: a prospective multicenter study 2004

[3] Postmenopausal vaginal bleeding in women using hormone replacement therapy 2012